Heavy metals are important regulators of cell apoptosis. Manganese (Mn 2 þ ) is a potent inducer of apoptosis in different cell types, but the precise mechanisms that mediate such effects are not well defined. We previously reported that Mn 2 þ was a potent apoptotic agent in human B cells, including lymphoma B cell lines. We show here that Mn 2 þ -induced cell death in human B cells is associated with caspase-8-dependent mitochondrial activation leading to caspase-3 activity and apoptosis. We used specific caspase-8 interfering shRNAs to reduce caspase-8 expression, and this also reduced Mn 2 þ -induced caspase-3 activation and apoptosis. Mn 2 þ -triggered caspase-8 activation is associated with a specific pathway, which is independent of Fas-associated death domain protein, and dependent on the sequential activation of p38-mitogen-activated protein kinase (p38 MAPK) and mitogen-and stress-response kinase 1 (MSK1). Inhibition of p38 activity using either pharmacological inhibitors or dominant-negative mutant forms of p38 blocked Mn 2 þ -mediated phosphorylation of MSK1 and blocked subsequent caspase-8 activation. However, specific inhibitors and the expression of a dominant-interfering mutant of MSK1 only inhibited caspase-8 activation, but not p38 activity. These findings suggest a novel model for the regulation of caspase-8 during Mn 2 þ -induced apoptosis based on the sequential activation of p38 MAPK, MSK1, caspase-8 and mitochondria, respectively.
Heavy metals are important regulators of cell apoptosis. Manganese (Mn 2 þ ) is a potent inducer of apoptosis in different cell types, but the precise mechanisms that mediate such effects are not well defined. We previously reported that Mn 2 þ was a potent apoptotic agent in human B cells, including lymphoma B cell lines. We show here that Mn 2 þ -induced cell death in human B cells is associated with caspase-8-dependent mitochondrial activation leading to caspase-3 activity and apoptosis. We used specific caspase-8 interfering shRNAs to reduce caspase-8 expression, and this also reduced Mn 2 þ -induced caspase-3 activation and apoptosis. Mn 2 þ -triggered caspase-8 activation is associated with a specific pathway, which is independent of Fas-associated death domain protein, and dependent on the sequential activation of p38-mitogen-activated protein kinase (p38 MAPK) and mitogen-and stress-response kinase 1 (MSK1). Inhibition of p38 activity using either pharmacological inhibitors or dominant-negative mutant forms of p38 blocked Mn 2 þ -mediated phosphorylation of MSK1 and blocked subsequent caspase-8 activation. However, specific inhibitors and the expression of a dominant-interfering mutant of MSK1 only inhibited caspase-8 activation, but not p38 activity. These findings suggest a novel model for the regulation of caspase-8 during Mn 2 þ -induced apoptosis based on the sequential activation of p38 MAPK, MSK1, caspase-8 and mitochondria, respectively. Cell Death and Differentiation (2007) 14, 1826-1836; doi:10.1038/sj.cdd.4402187; published online 22 June 2007 Exposure to divalent heavy metals such as manganese (Mn 2 þ ) has been linked to several neurological disorders, including Parkinson's-like syndrome. 1 High concentrations of Mn 2 þ can provoke a series of intracellular molecular events that lead to apoptosis. [2] [3] [4] [5] The mechanism by which Mn 2 þ induces cell death is somewhat controversial and not well understood. Several lines of evidence suggest that treatment of cells by Mn 2 þ induces different cellular changes, depending on the cell types studied. In neuronal cells, Mn 2 þ can be transported into the cells via the transport protein divalent metal transporter 1, a mechanism similar to that used for iron. 6, 7 This transport may generate increased oxidative stress with the subsequent induction of signal transduction pathways, leading to apoptosis. Reactive oxygen species (ROS) derived from mitochondrial damage have been implicated in cell-signaling pathways that lead to Mn 2 þ -induced apoptosis. 8 Recent data suggest that caspase-3-dependent proteolytic activation of PKCq plays a role in Mn 2 þ -induced apoptotic cell death. 9, 10 In HeLa and NIH3T3 cell lines, Mn 2 þ induces apoptosis via a caspase-12-dependent pathway, independent of the mitochondria and involving the participation of p-38 mitogen-activated protein kinases (MAPK). 3, 11 This suggests that transduction pathways mobilized by Mn 2 þ may differ according to the targeted cell. The MAPK are key regulators of cell proliferation, differentiation, survival and apoptosis. There are three major groups of MAPKs: extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK)/stress-activated protein kinase and p38 MAPK. The involvement of MAPK in the generation of stress responses, as well as in signaling for various cytokines and growth factors, has been extensively studied. [12] [13] [14] A variety of stress stimuli, including metals, engage the MAPK super family to participate in the apoptotic process. Among them, arsenic trioxide, which is a potent inducer of apoptosis, has been extensively studied. 15 In leukemia cells treated with arsenic trioxide, the p38 MAPK activating cascade acts as a negative regulatory feedback for antileukemic effects. 16 Downstream from the p38 MAPK activating pathway induced by arsenic, the stress-activated protein kinase 1 (MSK1) plays a role in this negative regulatory process. 17 On the other hand, oxidative stress in neurons initiates p-38 MAPK activation that is linked to caspase-8 and -9-dependent apoptosis. 18 We reported that p38 MAPK activation by transforming growth factor (TGF) b induces an apoptotic pathway via Fas-associated death domain protein (FADD)-independent activation of caspase-8 in human Burkitt lymphoma B cells. 19 We previously showed that Mn 2 þ induced apoptosis in human B cells. 5 This cell death was caspase-3-dependent and was inhibited by overexpression of Bcl-2 protein. 5, 20 We also showed that zinc, another divalent cation, exerted the opposite effect in human B lymphoma cells. 20 At low concentrations (o50 mM), zinc inhibited the loss of mitochondrial membrane potential (DCM) and the activation of both caspase-9 and caspase-3 associated with apoptosis induced by Mn 2 þ . Apoptosis induced by cellular stress is often mediated through the mitochondria-triggered cell death pathway. 21 As mitochondria participate in the apoptotic pathway induced by Mn 2 þ , we sought to identify their role in this process. In this study, we analyzed the upstream effectors involved in the mitochondrial dysfunction pathway induced by Mn 2 þ in lymphoma B cells in more detail. We found that Mn 2 þ induced activation of caspase-8, which in turn regulated mitochondria aberrations associated with the release of cytochrome c (Cyt c) via the Bid cleavage molecule, followed by caspase-3 activation. The caspase-8 activation was independent of FADD. The use of short hairpin RNA (shRNA) specific for caspase-8 blocked caspase-3 activation and apoptosis. We showed that p38 MAPK and MSK1 were activated in response to Mn 2 þ cell treatment, and they were critical for caspase-8 activation. Using specific pharmacological inhibitors and dominant-negative mutants of p-38 MAPK and MSK1, we found that p38 MAPK is the upstream effector that controls the activation of MSK1; this sequence of events leads to the Mn 2 þ -dependent activation of caspase-8. Altogether, these data reveal a novel mechanism for regulating caspase-8 activity in human B cells based on the sequential activation of p-38 MAPK and MSK1 leading to caspase-8 and mitochondrial activation.
Results
Manganese-induced cell death occurs via the mitochondrial pathway and involves caspase-8 activation in human B cells. We initially reported that Mn 2 þ apoptosis in lymphoma B cell was caspase-3-dependent. 5 Other groups reported similar results using other cell types. 3, 22 Nevertheless, the pathway responsible for caspase-3 activation remains unclear. Oubrahim et al. 3 reported that Mn 2 þ -dependent caspase-3 in HeLa and NIH3T3 cell lines was independent of mitochondrial activation. In contrast, Figure 1 shows that Mn 2 þ leads to mitochondrial modifications in human lymphoma B cells. Similar kinetic dose-effect curves were observed in the BL41 Burkitt lymphoma cell line treated with Mn 2 þ , with regard to apoptosis quantified by cell shrinkage or mitochondrial alterations quantified by mitochondrial membrane potential loss (DCM) measured either using 3,39-dihexylocarbocyanin iodide (DIOC6) or the MitoTracker Red CMXRos (data not shown) (Figure 1a ). Mn 2 þ (400 mM) induced the release of mitochondrial Cyt c into the cytosol with similar kinetics. Mitochondrial modifications, as measured by both criteria (DCM and Cyt c release), were observed after 8 h of activation by 400 mM Mn 2 þ with a maximum at 14 h (Figure 1a and b) .
Since caspase-8 is an important regulator of mitochondrial activation, we investigated its involvement during Mn 2 þ activation of BL41 cells. Figure 1c shows that caspases were responsible for mitochondrial activation since DCM loss was prevented by the pan-caspase inhibitor Z-Val-Ala-DL-Aspfluoromethylketone (zVAD-fmk) (50 mM) and by the more specific caspase-8 inhibitor Ala-Glu-Val-Asp-fluoromethyl ketone (AEVD-fmk) (50 mM), suggesting that DCM loss was dependent on caspase-8 activation. We further verified that Mn 2 þ could activate caspase-8 ( Figure 1d ). The presence of Mn 2 þ (400 mM) induced the expression of the p43/45 kDa and p18 cleaved active forms of caspase-8. Caspase-8 activation in BL41 cells was observed as early as 7 h after adding Mn 2 þ (43/45 kDa). The kinetics were confirmed by studying the cleavage of the natural caspase-8 substrate, Bid. Cleavage of Bid was observed after 7 h of Mn 2 þ treatment and was nearly complete after 9 h (Figure 1d ). Caspase-3 activation was more delayed than caspase-8 activation, starting after 9 h and it was more pronounced after 11 h.
These data showed that Mn 2 þ could activate caspase-8, as shown by Bid cleavage, and that Mn 2 þ treatment caused mitochondrial DCM loss and Cyt c release.
Caspase-8 is indispensable for Mn 2 þ -triggered mitochondrial activation and caspase-3 activation. To characterize the precise relationship between caspase-8 and caspase-3, we determined whether or not inhibition of caspase-8 in the presence of the specific inhibitors (Ile-GluThr-Asp-fluoromethyl ketone (IETD-fmk) and AEVD-fmk) could prevent caspase-3 activation. In Figure 2a , 50 mM IETD and 50 mM AEVD prevented both caspase-8 and caspase-3 activity, as measured by the fixation of their specific fluorogenic substrates. Similarly, Western blot analysis showed that the active cleaved forms of both caspase-8 and caspase-3 disappeared in the presence of the caspase-8 inhibitors IETD-fmk and AEVD-fmk (Figure 2b ). Both zVAD-fmk and IETD-fmk or AEVD-fmk inhibited, to a similar extent, the Mn 2 þ -induced cleavage of the natural caspase-3 substrate Mcl-1 (Figure 2b ). These data showed that Mn 2 þ -induced caspase-3 activation was dependent on caspase-8 activation. Figure 1 showed that caspase-8 could promote mitochondrial activation. We investigated whether caspase-8-dependent caspase-3 activation was mitochondria-dependent, using Ramos B lymphoma cell lines, one of which overexpressed Bcl-2. Normal Ramos cells were sensitive to Mn 2 þ -induced apoptosis and DCM decrease (Figure 3a ). Mn 2 þ (400 mM) stimulation of these cells was associated with caspase-8 and caspase-3 activation and Cyt c release (Figure 3a) . The kinetics of activation was faster than for BL41. Ectopic overexpression of Bcl-2 in Ramos B cells (Ramos/Bcl-2) rendered these cells resistant to Mn 2 þ -mediated apoptosis 5 ( Figure 3b ). Mitochondrial activation, as measured by DCM loss and Cyt c release, was inhibited in Ramos/Bcl-2 cells, and this inhibition was also associated with an inhibition of Mn 2 þ -induced caspase-3 activation. These data showed that Mn 2 þ -induced caspase-3 activation was dependent on the mitochondria. In contrast, activation of caspase-8 by Mn 2 þ was still observed in these cells. Altogether, these data are compatible with the hypothesis that caspase-3 activation in Mn 2 þ -treated human lymphoma B cells is directly controlled by caspase-8-mediated mitochondrial activation.
To establish the relevance of caspase-8 in the regulation of Mn 2 þ -induced apoptosis, we used specific shRNAs to reduce caspase-8 expression in a BJAB Burkitt lymphoma cell line. This cell line, which is also sensitive to Mn 2 þ -induced apoptosis, could be transfected to a higher level than the BL41 or Ramos cell lines. In the presence of the scrambled shRNA, Mn 2 þ promoted DCM loss, apoptosis and caspase-8 and caspase-3 activation (Figure 4) . Transfection of cells with the caspase-8 shRNA 23 resulted in a knockdown of the caspase-8 54/55 kDa pro-form expression. As illustrated in Figure 4 , knockdown of caspase-8 in the presence of Mn 2 þ was followed by a significant decrease in caspase-8 and caspase-3 activation, and was associated with an inhibition of apoptosis. These data strengthened our hypothesis that Mn 2 þ activates caspase-8, which in turn sequentially activates mitochondria and caspase-3.
Manganese-mediated caspase-8 activation is FADDindependent and requires activation of p38 MAPK. We next investigated the pathway responsible for Mn 2 þ -induced caspase-8 activation. First, we verified the involvement of the FADD molecule, the classical death domain adapter molecule for caspase-8 recruitment. We used FADDdominant-negative BL41 clones that we previously described and which did not respond to tumor necrosis factor (TNF)- promoted caspase-8 activation in these clones and this activation was associated with a DCM decrease and apoptosis, with similar kinetics to what had been observed in BL41 cells (Figure 1d and Figure 5b ). Therefore, activation of caspase-8 by Mn 2 þ is probably independent of the FADD adapter pathway.
To characterize the transduction pathway responsible for Mn 2 þ -induced caspase-8 activation, we used different pharmacological inhibitors specific for various kinases, which play important roles in early transduction pathways. Among the different inhibitors tested (Figure 6 ), we observed a significant decrease in the expression of active cleaved forms of caspase-8 in the presence of the p38 MAPK selective inhibitor SB203580. We also observed a significant decrease in caspase-8 cleavage in the presence of H89, a broad specificity kinase inhibitor that can inhibit the p38 target MSK1, among several other Ser/Thr kinases. 25 Inhibitors of other MAP-kinases, such as ERK (U0126 and PD98059) or JNK (SP600125), had little effect. Similarly, no modification of the PI3kinase pathway was observed in the presence of its specific inhibitors LY294002 and Wortmannin. Caspase-8 activation was inhibited by the pan-caspase inhibitor zVADfmk, and by the more specific caspase-8 inhibitor AEVD. Other proteases, such as calpain, which may be responsible for Mn 2 þ -mediated apoptosis in other cell types, 11 were probably not involved in our system since the specific calpain inhibitor ALLM (40 mM) did not prevent caspase-8 and caspase-3 activation, or apoptosis triggered by Mn 2 þ in BL41 cells. This pattern of reactivity was also observed with all the caspase-8 downstream events studied, which included cleavage of the caspase-8 substrate Bid, DCM decrease, caspase-3 activation and apoptosis (Figure 6a) . We checked the ability of all these inhibitors to prevent in vitro caspase-8 activation using the synthetic substrate caspatag-8 ( Figure 6b ). Again, SB203580 and H89 significantly inhibited caspase-8 activity, confirming a role for p38 and MSK1 in Mn 2 þ -mediated caspase-8 activation. were assessed by flow cytometry (a1, b1), as described in Figure 1 . Data represent the mean7S.D. of three determinations. Whole cell extracts were subjected to SDS-PAGE, and the cleaved fragments of caspase-8 and caspase-3 were detected by immunoblotting with anti-caspase-8 Ab (a2, b2), anti-caspase-3 Ab (a4, b4) and anti-actin Ab (a2, b2). Cytosolic and heavy membrane (enriched in mitochondria) extracts were prepared from Ramos (a3) and Ramos-bcl-2 (b3) cells cultured without (À) or with 400 mM Mn 2 þ for various periods of time. Immunoblots were probed with anticytochrome c Ab Manganese-induced phosphorylation and activation of MSK1 are dependent on p38 MAPK activity. We next studied the ability of Mn 2 þ to trigger activation of p38 and MSK1. As illustrated in Figure 7a , active phospho-p38 was detected by Western blot as early as 30 min after stimulation by 400 mM Mn 2 þ , and it reached a plateau of activation after 6 h. Mn 2 þ also induced phosphorylation of MSK1, but with delayed kinetics when compared to p38 (phospho-MSK1 appeared only after 3-4 h of stimulation and reached a plateau after 6 h of incubation). These data showed that (1) Mn 2 þ activated p38 and MSK1 in BL41 cells and (2) p38 was phosphorylated more rapidly than MSK1. This suggested that p38 may be responsible for the activation of MSK1 in Mn 2 þ -treated BL41 cells, which would support our previous report using different experimental conditions. 26 We studied the phosphorylation of p38 and MSK1 in the presence of various specific inhibitors to confirm the involvement of p38 in MSK1 activation by Mn 2 þ (Figure 7b ). MSK1 phosphorylation was only prevented in the presence of the p38-selective inhibitor SB203580; as control H89 did not inhibit p38 phosphorylation, although the concentration used (5 mM) prevented Mn 2 þ -induced apoptosis. These data strongly suggested that under our experimental conditions, activation of MSK1 was dependent on p38 activation. These data also showed that p38 and MSK1 activation was caspase-independent since neither the pan caspase inhibitor (zVAD-fmk) nor the more specific caspase-8 (IETD) or caspase-3 (DEVD) inhibitors inhibited the sequential p38/MSK1 activation.
Overexpression of p38 MAPK and MSK1 dominantnegative mutants regulate caspase-8 activation by Mn 2 þ . The preceding results showed that p38 activation was required for Mn 2 þ -induced caspase-8 activation and raised the possibility that MSK1, an H89-sensitive kinase and known p38 target, might also be involved. Consequently, experiments were designed to test this. The pattern of reactivity in BJAB cells in response to Mn 2 þ was similar to that previously observed in BL41 and Ramos cells, but with more delayed kinetics (Figure 8a) . All of the following experiments were performed after 24 h of activation with 400 mM Mn 2 þ (Figure 8b ). Overexpression of a dominantnegative form of p38 (p38AF) strongly prevented the expression of phospho-p38, phospho-MSK1 and active caspase-8 promoted by Mn 2 þ . Similarly, MSK1 and caspase-8 activation were prevented by the specific p38 inhibitor SB203580. In contrast, Mn 2 þ activated MSK1 and caspase-8 in BJAB cells transfected with the pcMV5 plasmid control or with wild-type p38. Overexpression of the dominant-negative MSK1 form, which is mutated in the active kinase site (MSK1 CKD), did not prevent Mn 2 þ -mediated p38 phosphorylation, but inhibited the appearance of active caspase-8 ( Figure 8c ). Levels of caspase-8 activation induced by Mn 2 þ were similar in pCMV5 control transfected cells and in BJAB cells transfected with wild-type MSK1 plasmid. The pivotal roles of p38 MAPK and MSK1 for caspase-8 activation were highlighted by the observation that simultaneous overexpression of both active p38 and MSK1 seemed to be sufficient to promote caspase-8 activation. Altogether, our data strongly suggested that Mn 2 þ -triggered apoptosis is dependent on the sequential activation of p38, MSK1, caspase-8 and caspase-3.
Discussion
We previously reported that Mn 2 þ promoted apoptosis of human B cells via a caspase-3-dependent pathway, 5 an observation that was confirmed by another group using other cell types, including HeLa and NIH3T3 cells. 3, 11 This group reported that caspase-3 activation was independent of the mitochondrial pathway 3 and dependent on caspase-12 activation. 11 Since the active form of caspase-12 was very limited in certain human ethnic groups, and since we had observed that Mn 2 þ could trigger apoptosis in all human B cell types from many different individuals, we decided to investigate Mn 2 þ -mobilized pathways upstream of caspase-3 activation in human B cells. Caspase-3 can be activated via mitochondrial-dependent or -independent pathways. In contrast to recent evidence suggesting no role for mitochondria in Mn 2 þ -induced apoptosis, 3 our data clearly show that (1) Mn 2 þ induces DCM loss and mitochondrial Cyt c release, (2) overexpression of Bcl-2 prevents Cyt c release and caspase-3 activation and (3) Mn 2 þ -induced mitochondrial alterations control caspase-3 activation 5 ( Figure 3 ). These effects were observed with concentrations of Mn 2 þ as low as 200 mM, although the maximum effect was observed with 400 mM. B cells were more sensitive to Mn 2 þ than HeLa or NIH3T3 cells, since experiments using these cells 3,11 used a concentration of 1 mM Mn 2 þ to promote cell death, whereas a single dose of 200 mM Mn 2 þ was sufficient to promote apoptosis and In our experimental model, mitochondrial activation was sensitive to the pan caspase inhibitor zVAD-fmk, clearly demonstrating the involvement of caspase-8 in this process. Mn 2 þ activated caspase-8, as demonstrated by the appearance of the active cleaved forms, cleavage of the natural substrate Bid, or fixation of the specific synthetic substrate Caspatag-8. The role of caspase-8 in mitochondrial activation and in caspase-3 activation was supported by the ability of specific caspase-8 inhibitors (IETD and AEVD) to prevent activation. Caspase-8 can activate caspase-3 through different pathways, either directly (type I) or through mitochondria (type II). 27, 28 Mn 2 þ -induced caspase-3 activation was more similar to the type II pathway, since Bcl-2 overexpression, which inhibits Cyt c release and completely abrogates caspase-3 activation, did not prevent caspase-8 activation. Thus, in lymphoma B cells, Mn 2 þ -induced caspase-3 activation is dependent on caspase-8-mediated mitochondrial activation.
The major pathway of caspase-8 activation is based on death receptor-dependent recruitment of the FADD adapter molecule, which in turn promotes dimerization and subsequent activation of this caspase. 29 Mn 2 þ -mediated caspase-8 activation was independent of the classical FADD pathway in our model since overexpression of a dominant-negative form of FADD lacking the DED domain that abolished the TRAIL response 24 ( Figure 5 ) did not prevent caspase-8 activation and apoptosis triggered by Mn 2 þ . Similar FADD-independent caspase-8 activation has already been described in other models using other apoptotic stimuli. 19, 24, 30 We could not exclude that interaction between the non-DED domain of FADD with caspase-8 might be involved in Mn 2 þ -mediated caspase-8 activation as it has been reported in another system. 31 However, we have not observed such an association using our experimental conditions (data not shown). We previously reported that p38 MAPK was involved in the control of caspase-8 activation by TGFb, 19 and we observed that Mn 2 þ triggered p38 activation in lymphoma B cells, as has been observed in other cell types. 4, 11, 22, 32 Here, we show that p38 is responsible for Mn 2 þ -directed caspase-8 activation in human B cells.
The exact pathway responsible for p38-MAPK activation under our experimental conditions is not yet defined. The generation of ROS can trigger p38-MAPK activation. 18, 33 Since ROS generation is often associated with metal exposure, excessive ROS production is an important pathway by which metals can induce apoptosis. 34 In a lethal concentration range, Mn 2 þ induced the production of ROS, which is known to cause mitochondria-mediated apoptosis. 35 However, in HeLa cells, Mn 2 þ -induced apoptosis was not were assessed by flow cytometry, as described in Figure 1 . Whole cell extracts were subjected to SDS-PAGE, and the cleavage of caspase-8 was determined with anti caspase-8 Abs. The data represent the means7S.D. of three individual measurements. Results from one experiment out of three performed are shown mediated by mitochondria even though more ROS and caspase-3 activation was observed. 3 The potential roles of ROS and mitochondria, and the activation of several pathways have been established for different metals. 34 In our model, using different inhibitors that regulated ROS production, we did not find any reduction in apoptotic level (data not shown), suggesting that ROS did not play any role in Mn 2 þ -induced cell death in Burkitt lymphoma cells.
A role for p38-MAPK in caspase-8 activation has been reported in various models. 18, 36, 37 However, the mechanism of this activation is still poorly understood. P38-MAPKmediated cell death signal initiated by ROS is linked to activation of caspase-8 in neuronal cell lines.
18 P38-MAPK might regulate caspase-8 activation through direct molecular interactions leading to the regulation of caspase-8 activity. In neutrophils, p38-MAPK can directly phosphorylate and inhibit caspase-8 activity and apoptosis. 36 We did co-immunoprecipitations, but we could not find any association of caspase-8 with p38-MAPK in either inactive or active forms (data not shown) under our experimental conditions, suggesting that p38 does not react directly with caspase-8, but rather mobilizes other molecules to activate caspase-8. The p38-mediated activation of caspase-8 by Mn 2 þ is dependent on MSK1 activation in lymphoma B cell lines. This raises the question of how MSK1 activates caspase-8. At least two mechanisms are possible: regulation of the transcription of regulator factors of caspase-8, or direct or indirect molecular interactions of caspase-8 with MSK1, leading to caspase-8 activation. The p38-MSK1 pathway is involved in transcriptional regulation, and we recently reported that association of the transcription factors SMAD3 and p300 triggered by TGFb might represent an alternative pathway.
26 P38-MAPK/MSK1-dependent caspase-8 activation triggered by Mn 2 þ may be related to regulation of transcription events. However, the addition of cycloheximide at non-toxic concentrations to prevent gene transcription (as measured by b-galactosidase activity in a gene reporter assay) did not prevent Mn 2 þ -induced caspase-8 activation (data not shown). The rapid kinetics of caspase-8 activation (as short as 4 h in Ramos B cells) is compatible with another mechanism for MSK1 activity, independent of its involvement in transcriptional regulation. We never observed any phosphorylation of caspase-8 after Mn 2 þ stimulation, or association of MSK1 with caspase-8 by immunoprecipitation. A more likely hypothesis is that MSK1 might phosphorylate and activate other, as yet unidentified molecules that interact with and activate caspase-8. We are currently trying to characterize these potential modulators using mass-spectrometry analysis.
In conclusion, our results provide a novel and logical explanation for the molecular mechanism involved in the Mn 2 þ -induced apoptosis of human lymphoma B cells. The activation of caspase-8 induced by Mn 2 þ in these cells is associated with an original pathway, which is FADD-independent, and which is dependent on sequential p38-MAPK and MSK1 activation. Therefore, understanding the cascade of molecular signals in Mn 2 þ -induced apoptosis of human lymphoma B cells may be helpful for B cell tumor therapy, with regard to the model of arsenic trioxide treatment of acute promyelocytic leukemia. The pCMV5 vector alone or vectors expressing either wild-type p38a (p38 WT) or the dominant-negative form of p38 (p38 AF) were co-transfected with a GFPexpressing plasmid into BJAB cells by electroporation. Cells were incubated at 371C, 5% CO 2 for 24 h. GFP-positive cells were isolated by flow cytometry, plated and immediately treated with 400 mM Mn 2 þ for 24 h without (À) or in combination with 20 mM SB203580. Cell extracts were separated by SDS-PAGE and immunoblots were probed with anti-Flag (p38), anti-p-p38, anti-MSK1, anti-p-MSK1 and anti-caspase-8 Abs. (c) In addition to p38a WT and AF vectors, wild-type MSK1 (MSK1 WT) or dominant-negative MSK1 (MSK1 CKD) were co-transfected with GFP into BJAB cells by elecroporation. Cells were plated and incubated for 24 h. GFP-positive cells were purified by flow cytometry, plated and immediately treated with 400 mM Mn 2 þ for 24 h. Immunoblots were probed with anti-Flag (p38), anti-p-p38, anti-MSK1, anti-p-MSK1 and anti-caspase-8 Abs France). The Ramos and BJAB Burkitt's cell lines were obtained from the American Type Culture Collection. For Ramos-bcl-2 isolation, the pSFFV-bcl2-neo vector bearing the human bcl-2 cDNA was used to transfect Ramos cells by electroporation, and stable transfectants were isolated. The pCDNA3.0/FADD-DN vector (kindly provided by Dr. V Dixit, Genentech, San Francisco, CA, USA) carries a truncated FADD cDNA (aa 80/208) lacking the DED region. It was used to transfect BL41 cells by electroporation. Stable clonal transfectants were isolated. All cell lines were cultured in RPMI 1640 medium with Glutamax supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin, 100 mg/ml streptomycin, sodium pyruvate and nonessential amino acids (Life Technologies, Strasbourg, France).
Vectors. The FLAG-tagged versions of wild-type (WT) or dominant-negative forms (AF) of p38 were kindly provided by Dr. J Han. AF is a p38 mutant that cannot be phosphorylated because the TGY dual phosphorylation sites were changed to AGF. The expression vectors pCMV5-FLAG MSK1 WT and MSK1 dead kinase (MSK1 C-terminal kinase dead (CKD) and MSK1 N-terminal kinase dead (NKD)) were gifts from Dr. DR Alessi. The pLL3.7-GFP vector expressing shRNAs against caspase-8 (sh-Casp8), and the empty vector were both generous gifts from Dr. L Van Parijs. 23 As control for shRNA, we used a scrambled sequence (5 0 -AATCGCATAGCGTATGCCGTT-3 0 ).
Cell transfection. The Burkitt lymphoma cells BJAB were maintained in RPMI medium with 10% FCS. Each vector pCMV5, p38a (WT, AF), MSK1 WT and MSK1 (CKD, NKD) was cotransfected with GFP into (2 Â 10 7 ) cells by electroporation at 0.24 kV, 960 mF using a Bio-Rad apparatus. Cells were plated and incubated at 371C, 5% CO 2 for 24 h. After expression of GFP protein, cells were selected by flow cytometry, plated and immediately treated with 400 mM Mn 2 þ for 24 h. For pLL3.7 vectors expressing shRNAs Casp8-GFP, cells were transfected in the same conditions with these vectors, plated and incubated 48 h after expression of GFP protein; cells were selected by flow cytometry, replated and immediately incubated with Mn 2 þ for 24 h again.
Detection of apoptotic cells and analysis of DWM. Cells were washed in phosphate-buffered saline (PBS), pelleted and resuspended in PBS. Their dotblot light scatter profiles were analyzed by flow cytometry using a FACScan flow cytometer (BD Biosciences, Mountain View, CA, USA). Shrunken cells with relatively high side scatter and low forward scatter properties were considered to be apoptotic and were counted. The number of apoptotic cells was then expressed as a percentage of the total population. DCM was evaluated by staining cells (10 6 ) with DIOC6 at a final concentration of 40 nM (stock solution 40 mM in ethanol) for 15 min at 371C in the dark. The fluorescence emitted by cells was analyzed with a FACScan flow cytometer (BD Biosciences) using the fluorescence signal 1 channel.
Assay of caspase activity. Caspase activities were determined using the CaspaTag caspase-3 (Asp-Glu-Val-Asp (DEVD)), and caspase-8 (IETD) activity kits (Intergen, Purchase, NY, USA). These are carboxyfluorescein-labeled fluoromethyl ketone (FMK)-peptide inhibitors of caspases. These inhibitors are cell-permeable and noncytotoxic. Once inside the cell, the inhibitor binds covalently to the active caspase. Analysis of caspase activity was performed using flow cytometry. Briefly, cells were treated with Mn 2 þ (400 mM) with or without inhibitors and then incubated at 371C with 5% CO 2 for 13 h. Cells were then washed and resuspended in warmed, complete RPMI, supplemented with fluorochrome-peptide-fmk for 1 h at 371C below 5% CO 2 . Cells were washed and analyzed immediately by flow cytometry.
Western blotting. Cells were lysed in 20 mM Tris (pH 7.4) and 0.5% SDS in the presence of 10 U of Benzon nuclease (Merck Eurolab) for 5 min at room temperature and then boiled for 3 min. Aliquots of the supernatants were used for protein determination (microBCA protein assay, Pierce). Cell lysates were subjected to SDS-polyacrylamide gel electrophoresis, and the proteins were then electrophoretically transferred onto nitrocellulose filters. The filters were probed with anti-caspase-8 (clone 5F7; Upstate Biotechnology, Lake Placid, NY, USA), anti-Bid (Cell Signaling Technology), anti-Mcl-1 (Santa Cruz, CA, USA), anticaspase-3 (polyclonal rabbit anti-caspase-3 antiserum, BD Pharmingen, San Diego, CA, USA), anti-cytochrome c (7H8.2C12, BD Pharmingen) or anti-actin and antiFlag (Sigma, St. Louis, MO, USA). Antibody binding was detected by incubation with sheep anti-mouse or anti-rabbit IgG HRP-conjugated antibodies and chemiluminescence (West-pico or West femto, Pierce). Images were captured using a DDC camera (LAS-1000, Fuji) . To analyze the phosphorylated proteins, cells were disrupted on ice for 30 min in lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM ethylenediaminotetraacetic acid (EDTA), 1 mM ethylene glycol-bis(baminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycerol phosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin and 1 mM phenylmethylsulfonyl fluoride), centrifuged at 15 000 Â g for 15 min in a microcentrifuge, and levels of phosphorylated proteins of p-p38-MAPK, p-MSK1, total p38 and MSK1 were selectively measured by Western immunoblotting using specific antibodies: anti-p-p38 and anti-p-MSK1-Thr581 (Cell Signaling Technology, Beverly, MA, USA), anti-p38 and anti-MSK1 (Santa-Cruz, CA, USA).
Subcellular fractionation. Following induction of apoptosis, cytosolic and pellet (mitochondrial) fractions were generated using a digitonin-based subcellular fractionation technique. Briefly, 1 Â 10 7 cells were harvested by centrifugation at 800 Â g, washed in PBS, pH 7.2 and re-pelleted. Cells were digitonin-permeabilized for 5 min on ice at a density of 3 Â 10 7 /ml in cytosolic extraction buffer (250 mM sucrose, 70 mM KCl, 137 mM NaCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , pH 7.2, 100 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml leupeptin, 2 mg/ml aprotinin, containing 200 mg/ml digitonin). Plasma membrane permeabilization of cells was confirmed by staining in a 0.2% trypan blue solution. Cells were then centrifuged at 1000 Â g for 15 min at 41C. The supernatants (cytosolic fractions) were saved and the pellets solubilized in the same volume of mitochondrial lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 0.2% Triton X-100, 0.3% NP-40, 100 mM PMSF, 10 mg/ml leupeptin, 2 mg/ml aprotinin), followed by pelleting at 10 000 Â g for 10 min at 41C for the detection of Cyt c.
